Bibliography
- Wild S, Roglic G, Green A, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
- Henke BR, Sparks SM. Glycogen phosphorylase inhibitors. Mini Rev Med Chem 2006;6:845-57
- Treadway JL, Mendys P, Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Invest Drugs 2001;10(3):439-54
- Oikonomakos NG, Somsák L. Advances in glycogen phosphorylase inhibitor design. Curr Opin Investig Drugs 2008;9(4):379-95
- Baker DJ, Greenhaff PL, Macinnes A, The experimental Type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes 2006;55:1855-61
- Cohen P. The twentieth century struggle to decipher insulin signaling. Nat Rev Mol Cell Biol 2006;7:867-73
- Ferrera JC, Favreb C, Gomis RR, Control of glycogen deposition. FEBS Lett 2003;546:127-32
- DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303
- Roden M, Bernroider E. Hepatic glucose metabolism in humans–its role in health and disease. Best Pract Res Clin Endocrinol Metab 2003;17:365-83
- Newgard CB, Brady MJ, O'Doherty RM, Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 2000;49:1967-77
- Cohen PTW. Protein phosphatase 1-targeted in many directions. J Cell Sci 2002;115:241-56
- Doherty MJ, Moorhead G, Morrice N, Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1. FEBS Lett 1995;375:294-8
- Armstrong CG, Doherty MJ, Cohen PTW. Identification of the separate domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 that interact with phosphorylase a, glycogen and protein phosphatase 1. Biochem J 1998;336:699-704
- Kelsall IR, Munro S, Hallyburton I, The hepatic PP1 glycogen-targeting subunit interaction with phosphorylase a can be blocked by C-terminal tyrosine deletion or an indole drug. FEBS Lett 2007;581:4749-53
- Kelsall IR, Rosenzweig D, Cohen PTW. Disruption of the allosteric phosphorylase a regulation of the hepatic glycogen-targeted protein phosphatase 1 improves glucose tolerance in vivo. Cell Signal 2009;21:1123-34
- Alemany S, Cohen P. Phosphorylase a is an allosteric inhibitor of the glycogen and microsomal forms of rat hepatic protein phosphatase-1. FEBS Lett 1986;198:194-202
- Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
- Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31
- Medical Research Council. Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same. WO2000012549; 2000
- Zibrova D, Grempler R, Streicher R, Inhibition of the interaction between protein phosphatase 1 glycogentargeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Biochem J 2008;412:359-66
- Pautsch A, Stadler N, Wissdorf O, Molecular recognition of the protein phoshpatase 1 glycogen targeting subunit by glycogen phosphorylase. J Biol Chem 2008;283(14):8913-8
- Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans 2004;32:803-8